The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells.
Open accessAbstract
When a mouse osteoblastic cell line MC3T3-E1 was cultured in the presence of tumor necrosis factor alpha (TNF alpha), the release of prostaglandin E2 and the cyclooxygenase activity increased in a dose- and time-dependent manner. The increase of the enzyme activity was attributed mostly to the induction of cyclooxygenase-2 rather than cyclooxygenase-1 as judged by the inhibitory effect of NS398, Western blotting, and Northern blotting. In this system we attempted to elucidate the transcriptional regulation of the cyclooxygenase-2 gene. As examined by the luciferase assay, two positive regulatory regions (-186 to -131 and -512 to -385 base pairs) were found in the 5'-flanking promoter region of the mouse cyclooxygenase-2 gene in the TNF alpha-stimulated cells. The former included putative NF-IL6 (C/EBP beta) and AP2 elements, and the latter contained the NF kappa B motif. A DNA probe including the NF-IL6 and AP2 sites gave positive bands upon electrophoretic mobility shift assay using the nuclear extracts of MC3T3-E1 cells. The bands were supershifted by the addition of anti-NF-IL6 antibody but not by anti-AP2 antibody. A probe including the NF kappa B site also gave positive bands, which were supershifted by anti-NF kappa B p50 and p65 antibodies. Furthermore, when the motif of NF-IL6 or NF kappa B or both was subjected to point mutation, the luciferase activity was markedly reduced. These data suggested a potential role of both NF-IL6 and NF kappa B in the induction of cyclooxygenase-2 by TNF alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the conundrums is that IL-6 is remarkably noninflammatory in tissues, and although there are some reports that IL-6 induces PGs in non-CNS cells, this seems to be uncommon and to occur at quite high concentrations (57) despite the presence of a nuclear factor IL-6 site upstream of the COX-2 gene (58).”
From Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice (2003) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,754
Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.1.191 · Cited by 1,673
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,542
A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S. M., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,450
The inducible transcription activator NF-κB: regulation by distinct protein subunits
Baeuerle, P. A. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90007-8 · Cited by 1,025
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 902
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 821
Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., & Krönke, M. (1994) · Cell · doi:10.1016/0092-8674(94)90275-5 · Cited by 714
Flagged first, then by citations
Research works printed but not linked: 4
- Xie, 1994, Mol. Cell. Biol., 14, 6531
- Kusaka, 1988, Biochim. Biophys. Acta, 972, 339
- Isshiki, 1990, Mol. Cell. Biol., 10, 2757
- Baeuerle, 1991, Biochim. Biophys. Acta, 1072, 63
Cited by
Sorted by citations
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,622
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,973
Surh, Y., Chun, K., Cha, H.-H., Han, S. S., Keum, Y., Park, K.-K., & Lee, S. S. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Köenig, W., Habib, A., Merval, R., Lebret, M., Pineda‐Torra, I., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,138
“The activation of COX-2 transcription by proinflammatory cytokines occurs by activation of the NF-κB signalling pathwa”
Background15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 993
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Efficacy and Safety of Inhaled Corticosteroids: New Developments
Barnes, P. J., Pedersen, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
Recurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719
“Since COX-2 is a target gene for NF-kB (Yamamoto et al., 1995), which is thought to play a pivotal role in the pathogenesis of endome-”
BackgroundSchmedtje, J. F., Ji, Y.-S., Liu, W. L., DuBois, R. N., & Runge, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.601 · Cited by 668
Metal-induced oxidative stress and signal transduction
Leonard, S. S., Harris, G. K., & Shi, X. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.010 · Cited by 663
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C., & Price, J. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1192 · Cited by 583
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596
“Enzymes COX-2 (137), lipoxygenase (138), iNOS (139, 140),”
Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017400 · Cited by 532
“The expression of all three genes is regulated by NF- B (Yamamoto et al., 1995; Guttridge et al., 1999; Esteve et al., 2002).”
BackgroundDean, J. L. E., Brook, M., Clark, A. R., & Saklatvala, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.264 · Cited by 492
Hizaki, H., Segi‐Nishida, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10501 · Cited by 467
Holmes-McNary, M. Q., & Baldwin, A. S. (2019) · PubMed · doi:10.17615/wdcc-wb89 · Cited by 442
Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G., Volpert, O. V., Iñiguez, M. A., Lorenzo, E., Martı́nez-Martı́nez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 430
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 423
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 407
Traumatic Spinal Cord Injury Induces Nuclear Factor-κB Activation
Bethea, J. R., Castro, M., Keane, R. W., Lee, T. T., Dietrich, W. D., & Yezierski, R. P. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03251.1998 · Cited by 463
“…et al., 1994; Shohami et al., 1994; Hopkins and Rothwell, 1995; Merrill and Benveniste, 1996), prostaglandin synthase-2 (Shohami et al., 1988; Yamamoto et al., 1995; Adams et al., 1996; Nogawa et al., 1997), cell adhesion molecules (CAM) (Kaltschmidt et al., 1993; Jander et al., 1996;…”
BackgroundEvidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β
Newton, R. C., Kuitert, L. M. E., Bergmann, M., Adcock, I. M., & Barnes, P. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7064 · Cited by 390
An essential role for C/EBPβ in female reproductionPreprint
Sterneck, E., Tessarollo, L., & Johnson, P. F. (1997) · Genes & Development · doi:10.1101/gad.11.17.2153 · Cited by 387
“as well as in osteoblastic and endothelial cell lines (Sirois and Richards 1993; Inoue et al. 1995; Yamamoto et al. 1995).”
BackgroundShinmura, K., Tang, X., Wang, Y., Xuan, Y., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 375
Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway
Murakami, M., & Kudo, I. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00037-7 · Cited by 376
Shakibaei, M., John, T., Schulze-Tanzil, G. G., Lehmann, I., & Mobasheri, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.005 · Cited by 364
Anti-inflammatory activity of macrolide antibiotics
Michie, C. A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02441-3 · Cited by 356
Anti-Inflammatory Activity of Macrolide Antibiotics
Ianaro, A., Ialenti, A., Maffia, P., Sautebin, L., Rombolà, L., Carnuccio, R., Iuvone, T., D’Acquisto, F., & Rosa, M. D. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35272-3 · Cited by 348
“It is well known that the expression of several genes involved in the immune and inflammatory response (e.g., iNOS, COX-2, TNF-a, IL-1, IL-6) is regulated at the transcriptional level by the nuclear factor-kB (NF-kB) (Müller et al., 1993; Xie et al., 1994; Yamamoto et al., 1995).”
Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., & Araki, E. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2570 · Cited by 345
Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages
Wadleigh, D. J., Reddy, S. T., Kopp, E. B., Ghosh, S., & Herschman, H. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6259 · Cited by 341
Sandur, S. K., Ichikawa, H., Pandey, M. K., Kunnumakkara, A. B., Sung, B., Sethi, G., & Aggarwal, B. B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.009 · Cited by 337
Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
Mitchell, J. A., & Warner, T. D. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702897 · Cited by 324
“These pathways include, but are not limited to, reactive oxygen intermediates (Feng et al., 1995), NF-kB and NF-IL6 (Yamamoto et al., 1995), Ras/Rac1/ MEKK-1/JNK kinase/JNK signal transduction leading to phosphorylation of c-Jun (Xie & Herschman, 1996), ceramide (Hayakawa et al., 1996), mitogen-activated protein kinas…”
BackgroundWong, S. C. Y., Fukuchi, M., Melnyk, P. M., Rodger, I. W., & Giaid, A. (1998) · Circulation · doi:10.1161/01.cir.98.2.100 · Cited by 323
Sandur, S. K., Ichikawa, H., Sethi, G., Ahn, K. S., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601595200 · Cited by 329
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
Howe, L. R., Subbaramaiah, K., Brown, A. M. C., & Dannenberg, A. J. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080097 · Cited by 322
Transcription factors and asthma
Barnes, P. J., & Adcock, I. M. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12010221 · Cited by 321
“NF-κB also regulates the expression of inflammatory enzymes, including the inducible form of nitric oxide synthase (iNOS) that produces large amounts of NO [36] and inducible cyclo-oxygenase (COX-2) that produces prostanoids [37, 38].”
BackgroundSethi, G., Ahn, K. S., & Aggarwal, B. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2088 · Cited by 322
Takada, Y., Bhardwaj, A., Potdar, P. D., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 309
“NSAIDs inhibit TNF-induced and NF-kB-regulated protein expression Through activation of NF-kB, TNF induces cyclin D1 and COX-2, both of which have NF-kB-binding sites in their promoters (Yamamoto et al., 1995; Guttridge et al., 1999; Hinz et al., 1999).”
BackgroundUematsu, S., Matsumoto, M., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5811 · Cited by 308
The Spinal Phospholipase-Cyclooxygenase-Prostanoid Cascade in Nociceptive Processing
Svensson, C. I., & Yaksh, T. L. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.092401.143905 · Cited by 302
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
Xu, X.-M., Sansores-García, L., Chen, X.-M., Matijevic‐Aleksic, N., Du, M., & Wu, K. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5292 · Cited by 301
Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation
Kang, Y.-J., Mbonye, U. R., DeLong, C. J., Wada, M., & Smith, W. L. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.01.001 · Cited by 298
Physiological regulation of cyclooxygenase-2 in the kidney
Harris, R. C., & Breyer, M. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.1.f1 · Cited by 297
Amoura, Z., Koutouzov, S., Chabre, H., Cacoub, P., Amoura, I., Musset, L., Bach, J., & Pietté, J. C. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1 · Cited by 243
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
Expression from the human occludin promoter is affected by tumor necrosis factor α and interferon γ
Mankertz, J., Tavalali, S., Schmitz, H., Mankertz, A., Riecken, E. O., Fromm, M., & Schulzke, J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2085 · Cited by 287
Miettinen, S., Fusco, F. R., Yrjänheikki, J., Keinänen, R., Hirvonen, T. J., Roivainen, R., Närhi, M. V. O., Hökfelt, T. G. M., & Koıstınaho, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6500 · Cited by 276
Feedback control of cyclooxygenase-2 expression through PPARγ
Inoue, H., Tanabe, T., & Umesono, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001387200 · Cited by 276
Senftleben, U., & Karin, M. (2002) · PubMed · Cited by 272
Murono, S., Inoue, H., Tanabe, T., Joab, I., Yoshizaki, T., Furukawa, M., & Pagano, J. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121016998 · Cited by 271
Resveratrol: Preventing properties against vascular alterations and ageing
Delmas, D., Jannin, B., & Latruffe, N. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400098 · Cited by 277
D’Acquisto, F., Iuvone, T., Rombolà, L., Sautebin, L., Rosa, M. D., & Carnuccio, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01377-x · Cited by 269
Sung, B., Pandey, M. K., Ahn, K. S., Yi, T., Chaturvedi, M. M., Liu, M., & Aggarwal, B. B. (2008) · Blood · doi:10.1182/blood-2007-10-117994 · Cited by 265
Neuroprotective Effect of Quercetin Against the Detrimental Effects of LPS in the Adult Mouse Brain
Khan, A., Ali, T., Rehman, S. U., Khan, M. S., Alam, S. I., Ikram, M. A., Muhammad, T., Saeed, K. M., Badshah, H., & Kim, M. O. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01383 · Cited by 265
“TNF-α, IL-1β and reactive species such NO and iNOS induced the overexpression of COX2, which has a key role in the intensification of neuroinflammation-mediated neurodegeneration (Feng et al., 1995; Yamamoto et al., 1995; O’Banion et al., 1996; Salvemini, 1997).”
BackgroundShishodia, S., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408093200 · Cited by 265
Bolli, R. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00414-5 · Cited by 259
Effects of Resveratrol in Inflammatory Arthritis
Elmali, N., Baysal, Ö., Harma, A., Esenkaya, İ., & Mızrak, B. (2006) · Inflammation · doi:10.1007/s10753-006-9012-0 · Cited by 251
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01389-x · Cited by 250
Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide
Hwang, D. H., Jang, B. C., Yu, G., & Boudreau, M. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00154-8 · Cited by 248
Pandey, M. K., Sung, B., Ahn, K. S., Kunnumakkara, A. B., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2007-03-079616 · Cited by 247
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells
Strillacci, A., Griffoni, C., Sansone, P., Paterini, P., Piazzi, G., Lazzarini, G., Spisni, E., Pantaleo, M. A., Biasco, G., & Tomasi, V. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.12.010 · Cited by 244
Senftleben, U., & Karin, M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00003 · Cited by 290
Xie, W., & Herschman, H. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31742 · Cited by 239
Neuroprotective Strategies in Parkinson???s Disease
Mandel, S. A., Grünblatt, E., Riederer, P. F., Gerlach, M., Levites, Y., & Youdim, M. B. H. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00004 · Cited by 240
Differences in signaling pathways by IL-1β and IL-18
Lee, J.-K., Kim, S.-H., Lewis, E. C., Azam, T., Reznikov, L. L., & Dinarello, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402800101 · Cited by 237
Tian, B., Nowak, D. E., Jamaluddin, M., Wang, S., & Brasier, A. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500437200 · Cited by 237
Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies
D’Acquisto, F. (2002) · Molecular Interventions · doi:10.1124/mi.2.1.22 · Cited by 237
Paul‐Clark, M. J., Cao, T. V., Moradi‐Bidhendi, N., Cooper, D., & Gilroy, D. W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040566 · Cited by 234
Expression and Regulation of Cyclooxygenase‐2 in Rat Microglia
Bauer, M. K. A., Lieb, K., Schulze‐Osthoff, K., Berger, T., Gebicke‐Haerter, P. J., Bauer, J., & Fiebich, B. L. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00726.x · Cited by 235
Vitamin E and immune response in the aged: molecular mechanisms and clinical implications
Meydani, S. N., Han, S. N., & Wu, D. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00274.x · Cited by 234
IL-6-regulated transcription factors
Akira, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00063-0 · Cited by 231
NF-IL6 and NF-kappa B in cytokine gene regulation.
Akira, S., & Kishimoto, T. (1997) · PubMed · Cited by 231
miR‐301a as an NF‐κB activator in pancreatic cancer cells
Lu, Z., Li, Y., Takwi, A. A., Li, B., Zhang, J., Conklin, D. J., Young, K. H., Martin, R. C. G., & Li, Y. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.296 · Cited by 232
“We transfected PANC-1 cells with anti- miR-301a or an Nkrf overexpression construct and the Cox2 promoter upstream of a luc reporter (Yamamoto et al, 1995).”
MethodIchikawa, H., Takada, Y., Shishodia, S., Bolleddula, J., Nair, M. G., & Aggarwal, B. B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0096 · Cited by 225
“4B), which is a NF-nB-regulated gene product (35, 36).”
BackgroundCyclooxygenases and prostaglandins: shaping up the immune response
Rocca, B., & FitzGerald, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00204-1 · Cited by 222
Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis
Cui, X., Yu, J. H., Hofseth, A. B., Peña, E. A., Habiger, J., Chumanevich, A. A., Poudyal, D., Nagarkatti, M., Nagarkatti, P. S., Singh, U. P., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0117 · Cited by 221
“For immunohistochemical staining, serial sections of mouse colon tissues (processed as described above) were incubated with antibodies against inducible nitric oxide synthase (iNOS; mouse monoclonal clone 5D5-H7; diluted 1:10,000; Research & Diagnostic Antibodies), cyclooxygenase-2 (COX-2; rabbit polyclonal; diluted 1…”
BackgroundInfluentialTakada, Y., Ichikawa, H., Badmaev, V., & Aggarwal, B. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3127 · Cited by 215
Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Maffia, P., Patel, N. S. A., Paola, R. D., Ialenti, A., Genovese, T., Chatterjee, P. K., et al. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.056 · Cited by 214
RetractedLim, J. W., Kim, H., & Kim, K. H. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780243 · Cited by 210
“The promoter region of the human COX-2 gene contains two NF-k B consensus sites, and the expression of COX-2 is largely regulated by NF-k B in several cells (Hla and Neilson, 1992; Yamamoto et al, 1995).”
Iñiguez, M. A., Martı́nez-Martı́nez, S., Punzón, C., Redondo, J. M., & Fresno, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001381200 · Cited by 205
Caivano, M., & Cohen, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3018 · Cited by 204
“For example, NFkB is capable of activating a COX-2 promoter construct in IL-1 b-stimulated human pulmonary type II A549 cells (19), and mutation of the NF-kB response element partially inhibited TNFa-stimulated luciferase activity in transfected mouse osteoblastic MC3T3-E1 cells (20).”
BackgroundNewton, R. C., Seybold, J., Kuitert, L. M. E., Bergmann, M., & Barnes, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32312 · Cited by 197
NF-IL6 and NF-κB in Cytokine Gene Regulation
Akira, S., & Kishimoto, T. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60740-3 · Cited by 201
Li, F., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1470-4 · Cited by 199
“COX-2 has been also found to promote colon carcinoma-induced angiogenesis by producing important angiogenic factors (Tsujii et al. 1998).”
BackgroundInfluentialFaour, W. H., He, Y., He, Q. W., de Ladurantaye, M., Quintero, M. V., Mancini, A. D., & Battista, J. A. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104036200 · Cited by 198
Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells
Kim, Y., & Fischer, S. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27686 · Cited by 197
Chen, C., Sun, Y.-T., Chen, J., & Chiu, K.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2719 · Cited by 197
“However, another transcriptional factor, NF-IL-6, might also be involved, as reported in MC3T3-E1 cells (12).”
BackgroundTakada, Y., Murakami, A., & Aggarwal, B. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208845 · Cited by 199
“TNF has been shown to induce cyclin D1, c-Myc, COX-2, MMP-9, and ICAM-1, all of which have NF-kB binding sites in their promoters (Duyao et al., 1992; van de Stolpe et al., 1994; Yamamoto et al., 1995; Guttridge et al., 1999; Esteve et al., 2002).”
BackgroundSaliou, C., Kitazawa, M., McLaughlin, L., Yang, J., Lodge, J. K., Tetsuka, T., Iwasaki, K., Cillard, J., Okamoto, T., & Packer, L. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00212-3 · Cited by 190
Pandey, M. K., Sandur, S. K., Sung, B., Sethi, G., Kunnumakkara, A. B., & Aggarwal, B. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700890200 · Cited by 193
From chemoprevention to chemotherapy: common targets and common goals
Aggarwal, B. B., Takada, Y., & Oommen, O. V. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.10.1327 · Cited by 189
“NF-κB activation has been shown to regulate the expression of antiapoptotic proteins, such as B-cell leukaemia-2 (Bcl-2), long form of Bcl-x (Bcl-xL), survivin, TNF receptor-associated factor (TRAF)-1 and -2, cellular inhibitorof-apoptosis protein (cIAP), X-linked cIAP (XIAP) and cellular Fas-associated death domain p…”
BackgroundShishodia, S., Koul, D., & Aggarwal, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2011 · Cited by 185
“Although celecoxib is known to inhibit the activity of COX-2, our results indicate that it can also suppress the synthesis of COX-2, which is regulated by NF- B (48).”
BackgroundKeum, Y., Han, S. S., Chun, K., Park, K.-K., Park, J.-H., Lee, S. K., & Surh, Y. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00323-8 · Cited by 185
Inoue, H., & Tanabe, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8222 · Cited by 185
Sandur, S. K., Deorukhkar, A., Pandey, M. K., Pabón, A. M., Shentu, S., Guha, S., Aggarwal, B. B., & Krishnan, S. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.034 · Cited by 185
Metadata
- Authors
- Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S.
- Affiliations
- Tokushima University (JP)
- Corresponding author
- Yamamoto, Kei
- Yamamoto, Shozo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-12
- Volume
- 270
- Issue
- 52
- Pages
- 31315-31320
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002708977
- Cited by
- 647
- References
- 38
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 3 · 2021: 17 · 2020: 8 · 2019: 11 · 2018: 12 · 2017: 8 · 2016: 10 · 2015: 8 · 2014: 10 · 2013: 15 · 2012: 14
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Japan Foundation for Applied Enzymology
- Japan Research Foundation for Clinical Pharmacology
- Kissei
- Ono Pharmaceutical
- Japan Society for the Promotion of Science
- Daiichi Sankyo Company
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- cyclooxygenase-2, NF-κB, NF-IL6, C/EBPβ, TNF-α, transcriptional regulation, prostaglandin E2, MC3T3-E1 cells, osteoblasts, promoter regulation, gene induction
- MeSH terms
- Animals, Base Sequence, DNA-Binding Proteins, Enzyme Induction, Isoenzymes, Molecular Sequence Data, Nuclear Proteins, Oligodeoxyribonucleotides, Promoter Regions, Genetic, Prostaglandin-Endoperoxide Synthases, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Tumor Necrosis Factor-alpha, NF-kappa B, 3T3 Cells, CCAAT-Enhancer-Binding Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review